How to enhance non-thermal effects of ultrasound



The first melatonergic antidepressant - Valdoxan/Thymanax (agomelatine) - has received a positive opinion from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) for its use in the treatment of adult patients with major depressive disorder (MDD). Upon approval by the European Commission in early 2009, Valdoxan is expected to be

Full Post: Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder

In recent years HIFU has been widely used for the treatment of solid tumors, such as liver tumor, bone tumor, and breast cancer.

The mechanism for therapeutic actions of HIFU includes thermal effects and non-thermal effects with the latter dominated by cavitational effects. Adjusting acoustic parameters of pulsed high intensity focused ultrasound (PHIFU) can control thermal effects and non-thermal effects; short duty cycle and high intensity favors the occurrence of cavitation. Ultrasound contrast agent (UCA) can enhance cavitational effects. Lesions caused by non-thermal effects have characteristic pathological changes quite different from those of thermal lesions.

A research article to be published on November 21, 2008 in the World Journal of Gastroenterology addresses this question. The research group led by Professor Zhi-Biao Wang from Department of Biomedical Engineering of Chongqing Medical University used PHIFU with short duty cycle and high intensity combined with UCA to damage rabbit liver VX2 tumour by non-thermal effect, and the non-thermal damage was evaluated by histopathology.

Liver VX2 tumor model were established in 20 rabbits, which were then divided randomly into PHIFU combined with UCA group (PHIFU+UCA group) and sham group, with 10 rabbits in each group. In the PHIFU+UCA group, 0.2 mL of SonoVue was injected intravenously, followed by rapid injection of 1 mL normal saline. Fifteen seconds after the injection, the tumours were exposed to HIFU with ISP 5900W/cm2 for 90 seconds. Rabbits were sacrificed one day after HIFU exposure. Specimens of the exposed tumor tissues were obtained and observed pathologically under light microscope and transmission electron microscope. The remaining exposed tumor tissues were sent for TTC staining. Before TTC staining, tumor tissues in both the sham and the PHIFU+UCA group resembled gray fish meat; after TTC staining, the tumour tissues were uniformly stained red, with a clear boundary between tumor tissue and normal tissue. For PHIFU + UCA group, light microscopy displayed abundant vacuoles of various sizes in the cytoplasm and in some cells, chromatin margination and karyopyknosis were present. Electron microscopic examination revealed presence of karyopyknosis and chromatin margination in some cells, intercellular space widening, the presence of high electron-density apoptotic bodies and many vacuoles of various sizes in the cytoplasm.

This study found that PHIFU combination with UCA can enhance non-thermal effects of ultrasound, and the pathological characteristics of the non-thermal damage is different from those of thermal damage. Immunohistochemical detection found that PHIFU combined with UCA can promote tumor cell apoptosis and inhibit tumor cell proliferation, which will be reported in another article.

http://www.wjgnet.com/

Link




A Phase III clinical trial at New York University is investigating the safety and efficacy of High Intensity Focused Ultrasound (HIFU) for the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT) using the Sonablate(R) 500. Dr. Herbert Lepor, Chairman of Urology at NYU School of Medicine and medical monitor for

Full Post: Trial looks at high intensity focused ultrasound for locally recurrent prostate cancer



In a twist on nontraditional uses of ultrasound, a group of neuroscientists at Arizona State University has developed pulsed ultrasound techniques that can remotely stimulate brain circuit activity. Their findings, published in the Oct. 29 issue of the journal Public Library of Science (PLoS) One, provide insights into how low-power ultrasound can be harnessed

Full Post: Pulsed ultrasound used to remote control brain circuits



Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the diagnosis of invasive lobular carcinoma (ILC), a difficult to diagnose breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. When compared to mammography, ultrasound and

Full Post: Molecular breast imaging technique shows greater sensitivity over mammography, ultrasound and MRI for difficult to diagnose breast cancer



Dilon Technologies, Inc., the leader in molecular breast imaging, announced today that they have formed an alliance with Terason Ultrasound to offer an expanded imaging capability when molecular breast imaging and ultrasound may be required. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage

Full Post: Dilon Technologies forms alliance with Terason Ultrasound in diagnostic imaging



European researchers have developed highly sensitive ultrasound equipment that can detect tiny quantities of reflective microbubbles engineered to stick to specific tumour cells. The technique should pick up tumours early and improve patients’ chances of survival. Most of the current diagnostic methods - biopsy analysis, biochemical tests and medical imaging - are not sufficiently sensitive.

Full Post: Sensitive ultrasound to spot early-stage cancer